Oruka Therapeutics Inc.

NASDAQ: ORKA · Real-Time Price · USD
15.27
0.27 (1.80%)
At close: Aug 15, 2025, 2:49 PM

Oruka Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Net Income
-83.72M -9.93M -19.32M
Depreciation & Amortization
27K 114K 91K
Stock-Based Compensation
n/a n/a n/a
Other Working Capital
8.13M -878K 383K
Other Non-Cash Items
14.27M 561K 497K
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
11.59M -1.66M -28K
Operating Cash Flow
-57.84M -10.91M -18.76M
Capital Expenditures
-189K -2K -43K
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
-329.94M n/a n/a
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a
Investing Cash Flow
-330.13M -2K -43K
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a
Financial Cash Flow
449.54M n/a 23.09M
Net Cash Flow
24.14M -10.91M 4.29M
Free Cash Flow
-58.03M -10.91M -18.8M